soul trial oral semaglutide cardiovascular outcomes nejm 2025 results π Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no NEJM Editorial Fellow Harleen Marwah,
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23












.png)







![Motionless In White Decades [Explicit Content] (Black, Ruby & Tan Galaxy Colored Vinyl) (2 Lp's) Power Metal](https://cdn.shopify.com/s/files/1/0611/6212/7591/files/motionless-in-white-decades-explicit-content-black-ruby-tan-galaxy-colored-vinyl-2-lps_9ua8x.jpg?v=1784648792)



